GA HB1361

Prohibits sale or distribution of compounded weight loss drugs containing GLP-1 receptor agonists (like semaglutide/Ozempic) or GIP receptor agonists unless compounders meet strict pharmaceutical grade and quality control requirements

Requires compounders to use pharmaceutical grade ingredients with valid certificates of analysis, conduct quality control testing on both active ingredients and finished products, and verify manufacturing occurred at FDA-registered and inspected facilities

Mandates manufacturers and wholesalers provide written documentation of pharmaceutical grade status, certificates of analysis, quality control testing results, and sourcing information when selling compounding ingredients in Georgia

Requires entities selling compounded drugs to maintain records for at least two years after expiration and furnish records to the State Board of Pharmacy within one business day upon request

Violations result in a $1,000 fine per dose of illegally compounded drug sold and revocation of pharmacy or business license